WIM
AGIO icon

Woodford Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Woodford Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,214,459
Closed -$149M – 6
2019
Q1 		$149M Buy
2,214,459
+237,000
+12% +$13.8M 12.06% 3
2018
Q4 		$91.2M Buy
1,977,459
+660,000
+50% +$40.7M 7.89% 4
2018
Q3 		$102M Buy
1,317,459
+927,459
+238% +$74.6M 8.09% 6
2018
Q2 		$32.8M Buy
+390,000
New +$34M 3.98% 6

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Woodford Investment Management's AGIO Position: Q2 2019 in Review

Woodford Investment Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2019, closing a stake of 2,214,459 shares — an estimated $149M sold.

Woodford Investment Management first reported a position in AGIO in Q2 2018 and held it in 4 quarters. The position peaked at $149M in Q1 2019. 189 funds tracked by Wall St. Rank hold AGIO as of Q2 2019.

  • Woodford Investment Management reported no remaining Agios Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Woodford Investment Management sold 2,214,459 Agios Pharmaceuticals shares in Q2 2019, an estimated $149M.
  • Woodford Investment Management first reported a position in Agios Pharmaceuticals in Q2 2018 and held it in 4 quarters.
  • Woodford Investment Management's Agios Pharmaceuticals position peaked at $149M in Q1 2019.
  • 189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2019.

Based on Woodford Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.